Virtual Assessment of Imperata Cylindrica Root’s Bioactive Compounds as a Potential Inhibitor for Alpha-Glucosidase: the Study of Tengger Tribe’s Medicinal Plant doi.org/10.26538/tjnpr/v5i7.13

Main Article Content

Fatchur Rohman
Wira Eka Putra
Sustiprijatno
Diana Widiastuti

Abstract

One common clinical sign of type 2 diabetes mellitus is a high level of glucose in the blood. This condition leads to a worsen outcome for the patient and is often followed by a complication. Thus, the strategy to prevent this adverse effect is to inhibit  alpha-glucosidase activity, which was known as enzymes that convert carbohydrates into glucose. Indonesia, as a mega biodiversity country, has multiple type of medicinal plants that are used to ameliorate diseases. Tengger tribe, one of ethnic group of Javanese which live in eastern Java, has a local wisdom related to the medicinal plants. The present study aimed to virtually assess one of Tengger Tribe medicinal plants called Imperata cylindrica as an anti-diabetic agent. Virtual screening was performed to evaluate the bioactive compounds. Several indicators were measured, such as the minimum baseline for drug-like compounds candidate, binding affinity scores, chemicals interaction pattern, and residual amino acid between the ligand and the target protein. According to our findings, numerous bioactive compounds such as 5-methoxyflavone, 6-hydroxy-5-methoxyflavone, 7-hydroxy-4-methoxy-5-methylcoumarin, and Siderin have potency as drug-like compound and have higher binding affinity to the alpha glucosidase as target protein compared with Miglitol as a control drug for alpha-glucosidase. From this computational prediction, the future in vitro and in vivo study to evaluate 5-methoxyflavone, 6-hydroxy-5-methoxyflavone, 7-hydroxy-4-methoxy-5-methylcoumarin, and Siderin anti-diabetic effect against alpha-glucosidase is necessary.

Downloads

Download data is not yet available.

Article Details

How to Cite
Rohman, F., Putra, W. E., Sustiprijatno, & Widiastuti, D. (2021). Virtual Assessment of Imperata Cylindrica Root’s Bioactive Compounds as a Potential Inhibitor for Alpha-Glucosidase: the Study of Tengger Tribe’s Medicinal Plant: doi.org/10.26538/tjnpr/v5i7.13. Tropical Journal of Natural Product Research (TJNPR), 5(7), 1240-1245. https://tjnpr.org/index.php/home/article/view/484
Section
Articles
Author Biography

Wira Eka Putra, Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Negeri Malang, East Java, 65145, Indonesia

Department of Biotechnology, Faculty of Mathematics and Natural Sciences, Universitas Negeri Malang, East Java, 65145,Indonesia

How to Cite

Rohman, F., Putra, W. E., Sustiprijatno, & Widiastuti, D. (2021). Virtual Assessment of Imperata Cylindrica Root’s Bioactive Compounds as a Potential Inhibitor for Alpha-Glucosidase: the Study of Tengger Tribe’s Medicinal Plant: doi.org/10.26538/tjnpr/v5i7.13. Tropical Journal of Natural Product Research (TJNPR), 5(7), 1240-1245. https://tjnpr.org/index.php/home/article/view/484

References

Silva JAD, Souza ECF, Echazú Böschemeier AG, Costa CCMD, Bezerra HS, Feitosa EELC. Diagnosis of diabetes mellitus and living with a chronic condition: participatory study. BMC Public Health. 2018; 18(1):1-8.

Caro-Bautista J, Rodríguez-Blázquez C, Perez-Manchon D, Timonet-Andreu E, Carvajal-Carrascal G, Fuentes-Ramírez A, Corchon S, Aranda-Gallardo M, Ambrosio L. Validation of living with chronic illness scale in a type 2 diabetes mellitus population. Health Qual Life Outcomes. 2021; 19(1):1-10.

Rowley WR, Bezold C, Arikan Y, Byrne E, Krohe S. Diabetes 2030: Insights from Yesterday, Today, and Future Trends. Popul Health Manag. 2017; 20(1):6-12.

Thibault V, Bélanger M, LeBlanc E, Babin L, Halpine S, Greene B, Mancuso M. Factors that could explain the increasing prevalence of type 2 diabetes among adults in a Canadian province: a critical review and analysis. Diabetol. 2016; 8(71):1-10.

Wondmkun YT. Obesity, Insulin resistance, and type 2 diabetes: Associations and therapeutic implications. Diabetes Metab Syndr Obes. 2020; 13:3611-3616.

Nolan CJ and Prentki M. Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift. Diab Vasc Dis Res. 2019; 16(2):118-127.

Czech M. Insulin action and resistance in obesity and type 2 diabetes. Nat Med. 2017; 23:804-814.

Centers for Disease Control and Prevention (CDC). Prevalence of overweight and obesity among adults with diagnosed diabetes-United States, 1988-1994 and 1999-2002. Morb Mortal Wkly Rep 19. 2004; 53(45):1066-1068.

Bonini MG and Sargis RM. Environmental Toxicant Exposures and Type 2 Diabetes Mellitus: Two Interrelated Public Health Problems on the Rise. Curr Opin Toxicol. 2018; 7:52-59.

Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018; 41(12):2669-2701.

Peña AS, Curran JA, Fuery M, George C, Jefferies CA, Lobley K, Ludwig K, Maguire AM, Papadimos E, Peters A, Sellars F, Speight J, Titmuss A, Wilson D, Wong J, Worth C, Dahiya R. Screening, assessment and management of type 2 diabetes mellitus in children and adolescents: Australasian Paediatric Endocrine Group guidelines. Med J Aust. 2020; 213(1):30-43.

Pan B, Ge L, Xun Y, Chen Y, Gao C, Han X, Zuo L, Shan H, Yang K, Ding G, Tian J. Exercise training modalities in patients with type 2 diabetes mellitus: A systematic review and network meta-analysis. Int J Behav. 2018; 15(72): 1-14.

Nyenwe EA, Jerkins TW, Umpierrez GE, Kitabchia AE. Management of type 2 diabetes: Evolving strategies for the treatment of patients with type 2 diabetes. Obstet Gynecol Clin. 2011; 60(1):1-23.

Şöhretoğlu D and Sari S. Flavonoids as alpha-glucosidase inhibitors: mechanistic approaches merged with enzyme kinetics and molecular modelling. Phytochem Rev. 2020; 19:1081-1092.

Wachters-Hagedoorn RE, Priebe MG, Heimweg JA, Heiner AM, Elzinga H, Stellaard F, Vonk RJ. Low-dose acarbose does not delay digestion of starch but reduces its bioavailability. Diabet Med. 2007; 24(6):600-606.

Campbell LK, White JR, Campbell RK. Acarbose: Its role in the treatment of diabetes mellitus. Ann Pharmacother. 1996; 30(11):1255-1262.

Giada MLR. Food phenolic compounds: main classes, sources and their antioxidant power, oxidative stress and chronic degenerative diseases - A role for antioxidants. José A. MoralesGonzález, IntechOpen. 2013. 87-112 p.

Rohman F, Juma Y, Sulisetijono, Utomo DH, Purwanto, Lestari SR, Arifah SN, Putra WE. Plants diversity as a medicinal plants by the Tengger Tribe, Bromo Tengger Semeru National Park, East Java, Indonesia. Eurasia J Biosci. 2019; 13(2):2293-2298.

Liu R, Chen S, Ren G, Shao F, Huang H. Phenolic compounds from roots of Imperata cylindrica var. major. Chinese Herb. Med. 2013; 5(3):240-243.

Paetzab J and Schneider G. A neuro-fuzzy approach to virtual screening in molecular bioinformatics. Fuzzy Sets Syst. 2005; 152(1):67-82.

Terstappen GC and Reggiani A. In silico research in drug discovery. Trends Pharmacol. 2001; 22(1):23-26.

Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, Han L, He J, He S, Shoemaker BA, Wang J, Yu B, Zhang J, Bryant SH. PubChem Substance and Compound databases. Nucleic Acids Res. 2016; 44(1):1202-1213.

Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov. 2004; 1(4):337-341.

Putra WE and Rifa’i M. Evaluating the molecular interaction of Sambucus plant bioactive compounds toward TNF-R1 and TRAIL-R1/R2 as possible anti-cancer therapy based on traditional medicine: The bioinformatics study. Sci. Study Res Chem Chem Eng Biotechnol Food Ind. 2020; 21:357-365.

Putra WE, Salma WO, Rifa'i M. Anti-inflammatory activity of sambucus plant bioactive compounds against TNF-α and TRAIL as solution to overcome inflammation associated diseases: The insight from bioinformatics study. Nat Prod Sci. 2019; 25(3):215-221.

Putra WE, Salma WO, Widiastuti D, Kismurtono M. In silico screening of peroxisome proliferator activated receptor gamma (PPARG)-agonist from Eugenia jambolana bioactive compounds as potential anti-diabetic agent. Malaysian J Biochem Mol Biol. 2020; 23:142-146.

Pecoits-Filho R, Abensur H, Betônico CC, Machado AD, Parente EB, Queiroz M, Salles JE, Titan S, Vencio S. Interactions between kidney disease and diabetes: dangerous liaisons. Diabetol Metab Syndr. 2016; 8(50):1-21.

Canivell S and Gomis R. Diagnosis and classification of autoimmune diabetes mellitus. Autoimmun Rev. 2014; 13(4-5):403-407.

Alqahtani AS, Hidayathulla S, Rehman MT, El Gamal AA, AlMassarani S, Razmovski-Naumovski V, Alqahtani MS, El Dib RA, AlAjmi MF. Alpha-amylase and alpha-glucosidase enzyme inhibition and antioxidant potential of 3-oxolupenal and katononic acid isolated from Nuxia oppositifolia. Biomol. 2019; 10(1):1-19.

Kajaria D, Ranjana, Tripathi J, Tripathi YB, Tiwari S. In-vitro α amylase and glycosidase inhibitory effect of ethanolic extract of antiasthmatic drug - Shirishadi. J Adv Pharm Technol Res. 2013; 4(4):206-209.

Ageely H. Long-term diabetes-related severe complications among individuals with T2DM in Jazan, Saudi Arabia. J Acute Dis. 2019; 8:72-77.

Papatheodorou K, Banach M, Edmonds M, Papanas N, Papazoglou D. Complications of Diabetes. J Diabetes Res. 2015; 2015: 1-5.

Berg JM, Tymoczko JL, Stryer L. Biochemistry. 5th edition. New York: W H Freeman. Section 1.3, Chemical Bonds in Biochemistry. 2002; Available from: https://www.ncbi.nlm.nih.gov/books/NBK22567/. Accessed on 1st April 2021.

Minatel IO, Borges CV, Ferreira MI, Gomez HAG, Chen CO, Lima GPP. Phenolic compounds: Functional properties, impact of processing and bioavailability, phenolic compounds -biological activity, Marcos Soto-Hernandez, Mariana PalmaTenango and Maria del Rosario Garcia-Mateos. IntechOpen. 2017. 1-24 p.

Huang W-Y, Cai Y-Z, Zhang Y. Natural phenolic compounds from medicinal herbs and dietary plants: Potential use for cancer prevention. Nutr Cancer. 2009; 62(1):1-20.

Asgar MA. Anti-diabetic potential of phenolic compounds: A review. Int J Food Prop. 2013; 16(1):91-103.